BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15972154)

  • 21. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes.
    Scott SA; Nagl L; Tilley L; Liew YW; Condon J; Flower R; Hyland CA
    Transfusion; 2014 Nov; 54(11):2931-40. PubMed ID: 24894016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular genetic analysis of two individuals with weak D variant of the Rh blood type].
    He Y; Yu L; Xu D; Zhang J; Deng G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):492-495. PubMed ID: 33974264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ.
    Dezan MR; Guardalini LGO; Pessoa E; Ribeiro IH; Oliveira VB; Luz F; Novac DR; Gallucci A; Bonifácio S; Gomes F; Levi JE; Pereira AC; Krieger JE; Mendrone-Junior A; Rocha V; Dinardo CL
    Transfusion; 2018 Feb; 58(2):317-322. PubMed ID: 29193119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
    Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
    Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of RHD alleles present in serologically RHD-negative donors determined by a sensitive microplate technique.
    de Paula Vendrame TA; Prisco Arnoni C; Guilhem Muniz J; de Medeiros Person R; Pereira Cortez AJ; Roche Moreira Latini F; Castilho L
    Vox Sang; 2019 Nov; 114(8):869-875. PubMed ID: 31587310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
    Londero D; Fiorino M; Miotti V; de Angelis V
    Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RHD DNA screening for weak D, DEL and D+/- 'chimeras'.
    Gassner C; Rozman P
    Vox Sang; 2006 Aug; 91(2):184. PubMed ID: 16907882
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of RhD agglutination for the detection of weak D red cells by anti-D flow cytometry.
    Grey DE; Davies JI; Connolly M; Fong EA; Erber WN
    Clin Lab Haematol; 2005 Apr; 27(2):127-33. PubMed ID: 15784128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
    Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
    Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of DEL phenotype in D- blood donors in India.
    Chaudhary R; Verma S; Verma A
    Immunohematology; 2020 Dec; 36(4):133-136. PubMed ID: 33544618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RhC Phenotyping, Adsorption/Elution Test, and SSP-PCR: The Combined Test for D-Elute Phenotype Screening in Thai RhD-Negative Blood Donors.
    Srijinda S; Suwanasophon C; Visawapoka U; Pongsavee M
    ISRN Hematol; 2012; 2012():358316. PubMed ID: 23209920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RHD variants in Polish blood donors routinely typed as D-.
    Orzińska A; Guz K; Polin H; Pelc-Kłopotowska M; Bednarz J; Gieleżyńska A; Sliwa B; Kowalewska M; Pawłowska E; Włodarczyk B; Malaga Alicja Żmudzin M; Krzemienowska M; Srivastava K; Michalewska B; Gabriel C; Flegel WA; Brojer E
    Transfusion; 2013 Nov; 53(11 Suppl 2):2945-53. PubMed ID: 23634715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between serology and genetics of weak D types in Denmark.
    Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
    Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.
    Silvy M; Simon S; Gouvitsos J; Di Cristofaro J; Ferrera V; Chiaroni J; Bailly P
    Transfusion; 2011 Feb; 51(2):401-11. PubMed ID: 20723165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular background of weak D type 15 as the predominant weak D type found in Chinese population].
    Sun GD; Duan XM; Zhang YP; Yin ZZ; Niu XL; Li YF; Zhao YL; Niu HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1024-8. PubMed ID: 17096912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How I manage donors and patients with a weak D phenotype.
    Flegel WA
    Curr Opin Hematol; 2006 Nov; 13(6):476-83. PubMed ID: 17053462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.